Product Information
SODIUM POLYSTYRENE SULF POWDER is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.0924 per GM under NDC 11534016644. Its NADAC has been published 482 times since Jul 12, 2017.
FDA first approved this application on Nov 28, 2014. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the sodium polystyrene sulfonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4.1 meq/g
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534016644
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL; RECTAL
Effective Date
9/23/2026
Active Ingredients
SODIUM POLYSTYRENE SULFONATEApproval Type
Generic (ANDA)
FDA Application
ANDA204071FDA Approved
11/28/2014
TE Code
AA
On Market Since
1/24/2017
Price Statistics
The NADAC for SODIUM POLYSTYRENE SULF POWDER has been published 482 times since Jul 12, 2017, and over the history we have for it it has declined 17.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0924 per GM |
|---|---|
| All-time high | $0.1474 (Feb 14, 2024) |
| All-time low | $0.0541 (Oct 21, 2020) |
| 52-week high | $0.1094 |
| 52-week low | $0.0924 |
| Median price | $0.1013 |
| Average price | $0.1016 |
| Largest weekly change | +101.1% (Aug 18, 2021) |
| Weeks tracked | 482 |
| Tracking since | Jul 12, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sunrise Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sodium polystyrene sulfonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SODIUM POLYSTYRENE SULF POWDER?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM POLYSTYRENE SULF POWDER, manufactured by Sunrise Pharmaceutical Inc., is $0.0924 per GM (NDC 11534016644), effective Sep 30, 2026.
How has the price of SODIUM POLYSTYRENE SULF POWDER changed over time?
Over the history we have for it, the NADAC for SODIUM POLYSTYRENE SULF POWDER has declined 17.6%. It has been tracked across 482 weekly CMS publications since Jul 12, 2017.
What are the highest and lowest recorded NADAC prices for SODIUM POLYSTYRENE SULF POWDER?
Since Jul 12, 2017, the NADAC for SODIUM POLYSTYRENE SULF POWDER has ranged from a low of $0.0541 (Oct 21, 2020) to a high of $0.1474 (Feb 14, 2024), with a median of $0.1013 per GM.
Are there cheaper alternatives to SODIUM POLYSTYRENE SULF POWDER?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SODIUM POLYSTYRENE SULF POWDER in a comparable dosage form, but none are currently priced below it.
Who manufactures SODIUM POLYSTYRENE SULF POWDER?
SODIUM POLYSTYRENE SULF POWDER (NDC 11534016644) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.